# Injective EVM Token incentives Methodology

## 1. Overview

Token incentives measures the value of native assets paid out to supply-side or demand-side participants, core contributors, or investors. This metric is analogous to stock-based compensation in traditional finance. For Injective EVM, this metric is currently set to zero. While native staking rewards are generated at the Injective Cosmos level, no additional native asset incentives are emitted or distributed specifically within the Injective EVM environment.

## 2. Data sources

- **None**: This metric is set to a constant value and does not consume blockchain events.

## 3. Step-by-step calculation

### Component A: Constant value assignment

- **Purpose**: Establishes the token incentive value for the Injective EVM product.
- **Logic**: A constant value of zero is assigned to the metric for all daily timestamps. This reflects that native INJ emissions, such as staking rewards and minting events, are accounted for at the Injective Cosmos level rather than the Injective EVM execution layer. No secondary incentive programs involving native asset distributions are identified within the Injective EVM context.

*This methodology was automatically generated by Token Terminal's methodology analyzer.*

Value of native tokens distributed as incentives.

Token incentives

Blockchains (L1)

Validators process transactions and receive transactions fees (supply-side fees).

Injective is a smart contract platform for decentralized finance applications (a blockchain) and an orderbook exchange protocol. Injective was founded by Eric Chen, Albert Chon etc. and launched in 2020. Note that this dashboard only tracks Injective's blockchain business.

INJ holders own and govern the protocol. They currently take a cut of the total transaction fees paid by users (revenue) via Burn Auctions. Injective's investors include Binance, Jump Crypto, Mark Cuban, etc.

Injective EVM

Token incentives

Token incentives

Chain breakdown